Thursday, May 04, 2017 7:04:25 AM
Posted by Grant Hamersma on May 4th, 2017
ImmunoVaccine Inc. (TSE:IMV) insider Pierre Labbé acquired 10,000 shares of the business’s stock in a transaction that occurred on Monday, April 17th. The shares were purchased at an average cost of C$1.08 per share, for a total transaction of C$10,800.00.
Pierre Labbé also recently made the following trade(s):
On Tuesday, April 18th, Pierre Labbé acquired 10,000 shares of ImmunoVaccine stock. The shares were purchased at an average cost of C$1.13 per share, for a total transaction of C$11,300.00.
On Tuesday, February 28th, Pierre Labbé acquired 15,000 shares of ImmunoVaccine stock. The shares were purchased at an average cost of C$1.17 per share, for a total transaction of C$17,550.00.
On Monday, February 27th, Pierre Labbé purchased 10,000 shares of ImmunoVaccine stock. The shares were bought at an average cost of C$1.17 per share, for a total transaction of C$11,700.00.
On Monday, February 13th, Pierre Labbé purchased 2,400 shares of ImmunoVaccine stock. The shares were bought at an average cost of C$1.12 per share, for a total transaction of C$2,688.00.
On Tuesday, February 14th, Pierre Labbé purchased 5,000 shares of ImmunoVaccine stock. The shares were bought at an average cost of C$1.18 per share, for a total transaction of C$5,900.00.
Shares of ImmunoVaccine Inc. (TSE:IMV) opened at 1.61 on Thursday. ImmunoVaccine Inc. has a one year low of $0.51 and a one year high of $1.62. The stock’s market cap is $191.52 million. The stock’s 50 day moving average is $1.22 and its 200-day moving average is $0.94.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM